middle.news
How Resonance Health’s New Tech and Trials Are Driving Record Revenue Growth
10:14am on Friday 30th of January, 2026 AEDT
•
Healthcare
Read Story
How Resonance Health’s New Tech and Trials Are Driving Record Revenue Growth
10:14am on Friday 30th of January, 2026 AEDT
Key Points
Unaudited revenue hits $8.0M for 1HFY26 with improving margins
48 of 60 patients recruited in $13.8M major pharma clinical trial
TrialsWest clinics reach profitability and near breakeven ahead of schedule
SaMD forward orders and tender pipeline exceed $10M
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Resonance Health (ASX:RHT)
OPEN ARTICLE